General Clinical Chemistry Analyzers and Accessories
Rarecyte RareCyte RarePlex BT-474 spike-in CTC Control Slide, 10-Pack
A pack of ten, batch control slides to be stained, scanned, and reviewed with experimental slides. Control slides contain a monolayer of buffy coat and spiked-in BT-474 cells (epithelial cells from human breast carcinoma). This control slide is used to assess the performance of the immunofluorescent staining process for the detection of CTCs. Cells may be identified by biomarkers: Nuclear DNA, CK/EpCAM, CD45, HER2 and ER. Compatible kits: RareCyte RarePlex HER2/ER CTC Panel Kit, Ventana (SYTOX) (24-1257-002); CTC Panel Kit, Ventana (SYTOX) (24-1245-002); CTC Panel Kit, Leica (SYTOX) (24-1245-001); CTC Panel Kit, Ventana (Hoechst) (24-1277-002); CTC Panel Kit, Leica (Hoechst) (24-1277-001); CTC Panel Kit, Manual Staining (Hoechst) (24-1277-004); PD-L1 CTC Panel Kit, Ventana (24-1280-002); Developer Kit: 488 nm, Leica (28-1001-481); 405 nm, Leica (28-1001-401); 405 nm, Ventana (28-1001-402); 488 nm, Ventana(28-1001-482) and Cell Discovery Kit, Leica (24-1294-001).
Echelon Biosciences Research Labs SPHINGOSINE ARRAYS 2 pack
Sphingo Arrays are 4 x 5 cm hydrophobic membranes that have been spotted with a concentration gradient of eight different sphingolipids. They are used to determine the relative degree of binding of your protein of interest towards one or more of these lipids in a simple protein lipid overlay assay. Bound protein is then detected by an antibody against the protein or affinity tag. This item is non returnable
Abcam 4'-hydro x yazobenzene-2-carbo x ylic acid (HABA), 1G
MW 242.23 Da. An endogenous metabolite. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam YM-155, survivin inhibitor, 25MG
MW 443.3 Da, Purity >98%. Novel small molecule potent survivin suppressant. Inhibits survivin promoter activity (IC₅₀ = 0.54 nM) and down-regulates survivin in vitro and in vivo. Induces apoptosis in human tumor cell lines in vitro at 10 nM, with little effect on other IAP or Bcl-2 family members.
The product is subject to the following: Abcam Restricted Use Statement
Viva Products BJP-10/100 Clinical Concentrator
Clinical Ultrafiltration Concentrator; For concentration of proteins in clinical diagnostic samples such as urine and spinal fluid; Used prior to electrophoresis of monoclonal immunoglobulins (M-proteins) as well as immunofixation electrophoresis (IFE); Sample volume to 10 ml; Final concentrate volume as low as 50 microliters for 200X concentration factor; 7,500 MWCO; Includes disposable pipettes; Number of tests is 100/PK
Abcam INDY, DYRK1A/B inhibitor, 5MG
MW 235.3 Da, Purity >98%. Potent DYRK1A/B inhibitor (IC₅₀ values are 0.23 and 0.24 μM for DYRK1B and DYRK1A respectively). Also inhibits DYRK2, DTRK4, CLK1, CLK4, casein kinase 1 and PIM1 (> 90% inhibition at 10 μM). Reverses aberrant tau-phosphorylation and rescues repressed calcineurin/NFAT signaling. Impairs the self-renewal capacity of neural stem cells and glioblastoma tumor-initiating cells.
The product is subject to the following: Abcam Restricted Use Statement
Abcam LY2886721, BACE-1 inhibitor, 25MG
MW 390.4 Da, Purity >98%. Potent and selective BACE-1 inhibitor (IC₅₀ = 20.3 nM for recombinant hBACE-1). Human BACE2 is inhibited with an IC₅₀ of 10.2 nM. Does not inhibit other aspartyl proteases such as cathepsin D, pepsin, and renin. A potential agent to treat Alzheimer's Disease. Inhibits production of Aβ in HEK-293 Swe cells (IC₅₀ values are 18.5 nM and 19.7 nM for Aβ1-40 and Aβ1-42 respectively) and in PDAPP neuronal cells (IC₅₀ ~10 nM). Reduces dose-dependently brain levels of Aβ, C99 and sAPPβ in orally administered mouse model and plasma Aβ in dog model. Ppenetrates the blood-brain barrier.
The product is subject to the following: Abcam Restricted Use Statement
Abcam OSMI-1, O-GlcNAc transferase (OGT) inhibitor, 25MG
MW 563.6 Da, Purity >98%. Potent, cell-permeable, O-GlcNAc transferase (OGT) inhibitor. Inhibits protein O-GlcNAcylation in several mammalian cell lines without qualitatively altering cell surface N- or O-linked glycans.
The product is subject to the following: Abcam Restricted Use Statement
Abcam YM-155, survivin inhibitor, 5MG
MW 443.3 Da, Purity >98%. Novel small molecule potent survivin suppressant. Inhibits survivin promoter activity (IC₅₀ = 0.54 nM) and down-regulates survivin in vitro and in vivo. Induces apoptosis in human tumor cell lines in vitro at 10 nM, with little effect on other IAP or Bcl-2 family members.
The product is subject to the following: Abcam Restricted Use Statement